This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guo, Y. Articles by O'Brien, T. G. Search for Related Content PubMed PubMed Citation Articles by Guo, Y. Articles by O'Brien, T. G.

Haploinsufficiency for Odc Modifies Mouse Skin Tumor Susceptibility

¹ Lankenau Institute for Medical Research, Wynnewood, Pennsylvania and ² Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee

Requests for reprints: Thomas G. O'Brien, Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096. Phone: 610-645-8426; Fax: 610-645-2205; E-mail: obrient{at}mlhs.org.

Numerous studies have linked overexpression of ornithine decarboxylase (Odc) gene with enhanced susceptibility to mouse skin tumorigenesis. However, there is little experimental evidence suggesting that modest reductions in Odc expression might reduce tumor susceptibility. To address this issue, here we report the use of the Odc^+/– haploinsufficiency model, in which one copy of the murine Odc gene has been inactivated by a homologous recombination. Compared with Odc^+/+ mice, Odc^+/– mice exhibit reduced epidermal ODC enzyme activity and polyamine accumulation following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Furthermore, following chronic TPA treatment, the characteristic hyperplastic response of the epidermis was diminished in Odc^+/– mice. Finally, when subjected to a two-stage initiation-promotion protocol, substantially fewer skin papillomas developed in Odc^+/– mice compared with wild-type littermates. These results support the concept that differences in tissue polyamine levels, resulting from either overexpression or reductions in ODC, are important modifiers of tumor susceptibility.

Key Words: ornithine decarboxylase • polyamines • tumor promotion

This article has been cited by other articles:

				R. J. Rounbehler, W. Li, M. A. Hall, C. Yang, M. Fallahi, and J. L. Cleveland Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma Cancer Res., January 15, 2009; 69(2): 547 - 553. [Abstract] [Full Text] [PDF]

				K. J. Svensson, J. E. Welch, P. Kucharzewska, P. Bengtson, M. Bjurberg, S. Pahlman, G. B. Ten Dam, L. Persson, and M. Belting Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase Cancer Res., November 15, 2008; 68(22): 9291 - 9301. [Abstract] [Full Text] [PDF]

				D. Brennan, Y. Hu, S. Joubeh, Y. W. Choi, D. Whitaker-Menezes, T. O'Brien, J. Uitto, U. Rodeck, and M. G. Mahoney Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes J. Cell Sci., March 1, 2007; 120(5): 758 - 771. [Abstract] [Full Text] [PDF]

				A. E. Pegg Regulation of Ornithine Decarboxylase J. Biol. Chem., May 26, 2006; 281(21): 14529 - 14532. [Abstract] [Full Text] [PDF]

				D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis Carcinogenesis, May 1, 2006; 27(5): 1090 - 1098. [Abstract] [Full Text] [PDF]